CLOSED STUDIES / Ovarian Cancer



Randomized clinical trial of Paclitaxel / Epirubicin / Carboplatin in combination (TEC) vs. Paclitaxel / Carboplatin (TC) in the treatment of women with advanced ovarian cancer.

GEICO Coordinator

Dr. Miguel Angel Izquierdo / Dr. José María del Campo

Patients Recruited

38 patients

Inclusion Closing Date

August of 2001


Results on progression free survival. G. B. Kristensen, I. Vergote, E. Eisenhauer, M. Baekelandt, G. Stuart, E. Aavall-Lundquist, J. Del Campo, A. B. Lopez, M. Mirza, E. Lorenz; The Norwegian Radium Hospital, Oslo, Norway; University Hospital Gasthuisberg, Leuven, Belgium; NCI Canada Clinical Trials Group, Kingston, ON, Canada; Karolinska University Hospital, Stockholm, Sweden; Odense University Hospital, Odense, Denmark; University Hospital Trondheim, Trondheim, Norway. Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 22, No 14S (July 15 Supplement), 2004: 5003.